Your browser doesn't support javascript.
loading
Aprepitant for Patients Receiving Highly Emetogenic Chemotherapy: An Economic Analysis for Singapore.
Lopes, Gilberto; Burke, Thomas; Pellissier, James; Zhang, Xu-Hao; Dedhiya, Seema; Chan, Alexandre.
Afiliação
  • Lopes G; Medical Oncology, The Johns Hopkins Singapore International Medical Centre, Singapore; Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Burke T; Global Outcomes Research, Merck & Co., Inc., Whitehouse Station, NJ, USA.
  • Pellissier J; Health Economics Statistics, Merck & Co., Inc., Whitehouse Station, NJ, USA.
  • Zhang XH; Medical Affairs, Merck Sharp & Dhome (I.A.) Corp., Singapore.
  • Dedhiya S; Independent Health Economist, USA.
  • Chan A; Department of Pharmacy, National University of Singapore, Singapore; Department of Pharmacy, National Cancer Centre Singapore, Singapore. Electronic address: phaac@nus.edu.sg.
Value Health Reg Issues ; 1(1): 66-74, 2012 May.
Article em En | MEDLINE | ID: mdl-29702829
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Health_economic_evaluation / Prognostic_studies Idioma: En Ano de publicação: 2012 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Health_economic_evaluation / Prognostic_studies Idioma: En Ano de publicação: 2012 Tipo de documento: Article